Konferenzschrift | Kongress
Treatment options in ErbB2 (HER2)-Positive breast cancer : Symposium, November 2- 3, 2007, Munich ; 3 Tabellen
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783805585958
- Dimensions
-
30 cm
- Extent
-
23 S.
- Language
-
Englisch
- Notes
-
graph. Darst.
Literaturangaben
- Bibliographic citation
-
Breast care ; Vol. 3, Suppl. 1
- Keyword
-
Brustkrebs
Therapie
Krebs
Onkologie
Mamma
- Event
-
Veröffentlichung
- (where)
-
Basel, Freiburg, Br., Paris, London, New York, NY, Bangalore, Bangkok, Shanghai, Singapore, Tokyo, Sydney
- (who)
-
Karger
- (when)
-
2008
- Contributor
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.03.2025, 11:47 AM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Konferenzschrift
- Kongress
Associated
- Jackisch, Christian
- Karger
Time of origin
- 2008
Other Objects (12)
Photoimmunotherapy of HER2-expressing Breast Cancer Cells
Systemic therapy for women with ErbB2-positive breast cancer : new options, new challenges ; symposium, October 23 - 24, 2009, Munich ; 2 tables
EGFR Expression in HER2-Driven Breast Cancer Cells
Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer
Prognostic effect of HER2 evolution from primary breast cancer to breast cancer metastases
HER2 dynamics and EGF-NRG1 shape the response of HER2-targeted therapies in breast cancer
Exploring combination treatment with a HER2 and a Pirin inhibitor in HER2-overexpressing breast cancer cells
Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy
Die Interaktion von ErbB2/Her2 mit Hitzeschockproteinen in Mammakarzinomzellen
Immunotherapy: new options in breast cancer treatment
Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells
HER2 Dimerization Inhibitor Pertuzumab – Mode of Action and Clinical Data in Breast Cancer
Photoimmunotherapy of HER2-expressing Breast Cancer Cells
Systemic therapy for women with ErbB2-positive breast cancer : new options, new challenges ; symposium, October 23 - 24, 2009, Munich ; 2 tables
EGFR Expression in HER2-Driven Breast Cancer Cells
Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer
Prognostic effect of HER2 evolution from primary breast cancer to breast cancer metastases
HER2 dynamics and EGF-NRG1 shape the response of HER2-targeted therapies in breast cancer
Exploring combination treatment with a HER2 and a Pirin inhibitor in HER2-overexpressing breast cancer cells
Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy
Die Interaktion von ErbB2/Her2 mit Hitzeschockproteinen in Mammakarzinomzellen
Immunotherapy: new options in breast cancer treatment
Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells
HER2 Dimerization Inhibitor Pertuzumab – Mode of Action and Clinical Data in Breast Cancer
Photoimmunotherapy of HER2-expressing Breast Cancer Cells
Systemic therapy for women with ErbB2-positive breast cancer : new options, new challenges ; symposium, October 23 - 24, 2009, Munich ; 2 tables
EGFR Expression in HER2-Driven Breast Cancer Cells
Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer
Prognostic effect of HER2 evolution from primary breast cancer to breast cancer metastases
HER2 dynamics and EGF-NRG1 shape the response of HER2-targeted therapies in breast cancer
Exploring combination treatment with a HER2 and a Pirin inhibitor in HER2-overexpressing breast cancer cells
Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy
Die Interaktion von ErbB2/Her2 mit Hitzeschockproteinen in Mammakarzinomzellen
Immunotherapy: new options in breast cancer treatment
Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells